Immunocore (IMCR) Earnings Date, Estimates & Call Transcripts $32.25 -0.17 (-0.52%) (As of 12:50 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Immunocore Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 26EstimatedActual EPS (Nov. 6) $0.17 Beat By $0.50 Consensus EPS (Nov. 6) -$0.33 Immunocore issued Q3 2024 earnings on November 6, 2024, reporting an EPS of $0.17, which topped analysts' consensus estimates of -$0.33 by $0.50. Quarterly revenue rose 23.7% year-over-year to $80.25 million, above analyst estimates of $78.94 million. With a trailing EPS of -$0.95, Immunocore's earnings are expected to decrease next year, from ($0.94) to ($1.57) per share. Conference Call AudioIMCR Upcoming EarningsImmunocore's next earnings date is estimated for Wednesday, February 26, 2025, based off prior year's reporting schedules. Get Immunocore Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Immunocore and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIMCR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IMCR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. Immunocore Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$0.49-$0.42-$0.45Q2 20243-$0.53-$0.25-$0.41Q3 20243-$0.60-$0.38-$0.51Q4 20243-$0.93-$0.40-$0.70FY 202412-$2.55-$1.45-$2.08Q1 20251-$0.42-$0.42-$0.42Q2 20251-$0.48-$0.48-$0.48Q3 20251-$0.54-$0.54-$0.54Q4 20251-$0.96-$0.96-$0.96FY 20254($2.40)($2.40)($2.40) Immunocore Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/26/2025(Estimated)------- 11/6/2024Q3 2024-$0.33$0.17+$0.50$0.17$78.94M$80.25M 8/8/2024Q2 2024-$0.48-$0.23+$0.25-$0.23$74.58M$75.40M 5/8/2024Q1 2024-$0.37-$0.49 -$0.12-$0.49$70.72M$70.30M 2/28/2024Q4 2023-$0.28-$0.40 -$0.12-$0.40$53.25M$70.16M 11/7/2023Q3 2023-$0.32$0.04+$0.36$0.04$59.62M$62.89M 8/10/2023Q2 2023-$0.40-$0.37+$0.03-$0.37$59.39M$60.70M I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.5/10/2023Q1 2023-$0.30-$0.43 -$0.13-$0.43$49.39M$55.09M 3/1/2023Q4 2022$0.01-$0.63 -$0.64-$0.63$49.11M$58.04M Immunocore Earnings - Frequently Asked Questions When is Immunocore's earnings date? Immunocore has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates. Learn more on IMCR's earnings history. Did Immunocore beat their earnings estimates last quarter? In the previous quarter, Immunocore (NASDAQ:IMCR) reported $0.17 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.33) by $0.50. Learn more on analysts' earnings estimate vs. IMCR's actual earnings. How can I listen to Immunocore's earnings conference call? The conference call for Immunocore's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Immunocore generate each year? Immunocore (NASDAQ:IMCR) has a recorded annual revenue of $249.43 million. How much profit does Immunocore generate each year? Immunocore (NASDAQ:IMCR) has a recorded net income of -$55.29 million. IMCR has generated -$0.95 earnings per share over the last four quarters. What is Immunocore's EPS forecast for next year? Immunocore's earnings are expected to decrease from ($0.94) per share to ($1.57) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Blueprint Medicines Earnings Results Lantheus Earnings Results Nuvalent Earnings Results Viking Therapeutics Earnings Results Cytokinetics Earnings Results TG Therapeutics Earnings Results Crinetics Pharmaceuticals Earnings Results Avidity Biosciences Earnings Results Krystal Biotech Earnings Results ADMA Biologics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Election warning coming true… (Ad)If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. This page (NASDAQ:IMCR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunocore Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunocore With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
